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Abstract
Background: Decline in episodic memory is one of the hallmark features of Alzheimer’s disease (AD) and is also a
defining feature of amnestic Mild Cognitive Impairment (MCI), which is posited as a potential prodrome of AD.
While deficits in episodic memory are well documented in MCI, the nature of this impairment remains relatively
under-researched, particularly for those domains with direct relevance and meaning for the patient’s daily life. In
order to fully explore the impact of disruption to the episodic memory system on everyday memory in MCI, we
examined participants’ episodic memory capacity using a battery of experimental tasks with real-world relevance.
We investigated episodic acquisition and delayed recall (story-memory), associative memory (face-name pairings),
spatial memory (route learning and recall), and memory for everyday mundane events in 16 amnestic MCI and 18
control participants. Furthermore, we followed MCI participants longitudinally to gain preliminary evidence
regarding the possible predictive efficacy of these real-world episodic memory tasks for subsequent conversion to
AD.
Results: The most discriminating tests at baseline were measures of acquisition, delayed recall, and associative
memory, followed by everyday memory, and spatial memory tasks, with MCI patients scoring significantly lower
than controls. At follow-up (mean time elapsed: 22.4 months), 6 MCI cases had progressed to clinically probable
AD. Exploratory logistic regression analyses revealed that delayed associative memory performance at baseline was
a potential predictor of subsequent conversion to AD.
Conclusions: As a preliminary study, our findings suggest that simple associative memory paradigms with real-
world relevance represent an important line of enquiry in future longitudinal studies charting MCI progression over
time.
Background
Mild Cognitive Impairment (MCI) represents a potential
transitional stage between non-pathological aging and
Alzheimer’s disease (AD), referring to individuals who
display objectively measured cognitive deterioration in
the context of preserved functional capacity and the
absence of dementia [1]. Whilst MCI does not necessa-
rily represent a prodrome of AD, mounting evidence
suggests that within the subsample of amnestic multi-
domain MCI, an elevated risk for progression to demen-
tia exists [2,3]. Although MCI comprises a behaviourally
heterogeneous cohort [4], delayed memory testing and
recall-based assessments have been identified as the
most discriminating factors in flagging those individuals
at risk of progression to AD [5,6]. To date, the locus of
research has focused on episodic memory processes and
their vulnerability in MCI and AD; however, the nature
of this episodic deficit in MCI is relatively under-
researched [7]. Furthermore, the tests used to assess
memory deficits in MCI are often administered as part
of large neuropsychological batteries with little relevance
for participants’ everyday functioning.
One branch of episodic memory that has emerged as
particularly promising from a potential diagnostic per-
spective is that of associative memory [2,8]. Associative
memory refers to the linking of component parts, such
as words or objects, to create an integrated composite,
either directly or via spatial, temporal or other kinds of
relationships [9] and represents a fundamental feature of
episodic memory capacity. Anecdotal evidence from
MCI individuals and their family members suggests that
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nizing someone but failing to recollect the person’s
name or where they know the person from [10]. Face-
Name associative tasks represent an interesting analogue
of the associative encoding individuals are faced with in
daily life, and the formation of cross-modal associations
between inherently unrelated items of information is
likely to be hippocampal-dependent [11]. Furthermore
this branch of associative memory appears to be com-
promised in the earliest stages of AD whereas mixed
results have been obtained for MCI individuals [11].
Neuroimaging studies have shown marked reduction in
hippocampal and entorhinal cortex volumes in MCI
[12], with such pathology at a transitional level to nor-
mal aging and AD [13]. Importantly, these medial tem-
poral lobe regions are typically involved in episodic
memory [11] with a central role ascribed to the hippo-
campus for relational or associative memory [14,15].
Associative paradigms, however, are under-recognised in
this field, despite previous demonstrations of their abil-
ity to separate deteriorating from stable MCI at an early
stage [8]. From a clinical standpoint, therefore, the
encoding and retrieval of face-name pairs represents an
attractive method of investigating potential deficits in
associative memory in MCI.
A second branch of episodic memory with direct rele-
vance for everyday functioning that is commonly
affected in ageing relates to spatial navigation and way-
finding [16]. Spatial navigation refers to the process of
determining and maintaining a course or trajectory from
one place to another [17] and can be conceptualised as
allocentric (i.e., environment based [18]), or egocentric
(i.e., self based, [19]). The regions affected earliest in the
AD pathological disease process are thought to play cri-
tical roles in human navigation [20]. AD patients fre-
quently present with difficulties in spatial orientation in
everyday activities [21], often failing to find their way in
unfamiliar environments and new spatial settings during
travelling and shopping. Despite the importance of spa-
tial memory in everyday functioning, this area is less fre-
quently investigated particularly with respect to MCI
and dementia [22]. A number of recent studies have
demonstrated impairments in spatial memory in MCI
using virtual reality paradigms [23], analogues of the
Morris Water Maze task [24], and route-learning tasks
[25]. A selective impairment of spatial navigation has
been reported in multi-domain amnestic MCI [24], and
the authors argue that the disorientation commonly
observed in MCI is attributable to impaired spatial
memory. They further suggest that if spatial memory
begins to decline early in the disease process, presymp-
tomatic measures of spatial navigation may be useful
tools to detect individuals at risk of developing dementia
prior to the onset of clinical symptoms. Despite
mounting evidence for compromised spatial memory in
MCI, few neuropsychological studies have examined the
e x t e n tt ow h i c ht h i sb r a n c ho fe p i s o d i cm e m o r yi s
impaired in this clinical group.
The current picture suggests that episodic memory def-
icits are strong predictors of future progression to AD
[2]. Given that an amnesic syndrome is typically the ear-
liest symptom of AD [11], it is critical to understand the
nature of these deficits in MCI. The contribution of the
frontal lobes to episodic memory is well established [26],
and therefore it is also important to ascertain the degree
to which executive functions are compromised in amnes-
tic MCI, as recent studies have argued for the predictive
efficacy of such tests for the progression of MCI to AD
[4,27]. Exploring the spectrum of episodic memory
impairments in MCI affords us the opportunity to inves-
t i g a t et h ep o s s i b l ec l i n i c a lu t i l i t yo fe p i s o d i cm e m o r y
tasks, particularly those with direct relevance for every-
day functioning of participants. A strong rationale exists
for using experimental tasks with real-world meaning
given that functional decline is the key criterion for diag-
nosing AD. Accordingly, traditional single-memory tests
may not validly contribute to the differential diagnosis of
MCI and AD [22]. The aim of this study was to charac-
terise the nature of the memory impairment in MCI
using experimental tasks probing multiple domains of
episodic memory function. These include associative,
spatial and everyday memory tasks that are analogues of
real-world scenarios and are commonly encountered by
individuals in their daily lives. In addition, we aimed to
obtain preliminary data regarding which of these tasks, if
any, could potentially serve as an aid to identifying those
individuals in the prodrome of AD.
Results
Demographics
Controls ranged in age from 69-86 years (age: mean ±
SD = 76.0 ± 4.3) and had an average of 14.0 years (±
3.1) in formal education (range: 11-21 years). MCI parti-
cipants ranged in age from 62-88 years old (age: 71.8 ±
6.8) and spent an average of 13.8 years (± 4.7) in formal
education (range: 7.5-25 years). The two groups did not
differ for years in education, F(1,32) = 0.41, MSE = 0.64,
p = .841, however the MCI group was an average of 4.2
years younger than the control group, F(1, 32) = 4.658,
MSE = 148.53, p = .039. Sex was not evenly distributed
across the groups, c
2(33) = 5.673, p = .017, with a
female: male ratio of 14:4 in the control group com-
pared with 6:10 in the MCI group. These participant
groups have been described in a previous study [28].
Progression from MCI to AD
At follow-up, 6 of the 16 MCI participants (37.5%) had
converted to probable AD (MCIc), and 1 case was
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dementia (bvFTD), with the remaining 9 participants
representing stable MCI (MCIs). The bvFTD patient
was not included in any MCI subgroup analyses. Two
participants showed an increase in MMSE scores at fol-
low-up; however, this was not sufficient to denote a
return to healthy cognitive functioning, as evidenced by
persistent cognitive deficits, with neuropsychological test
scores falling below 1.5 standard deviations of age-
adjusted norms. Stable MCI cases scored on average
25.9 (± 0.8) on the MMSE in comparison with the con-
verted MCI cases who scored 23.5 (± 2.6) at follow-up.
None of the demographic variables were significant pre-
dictors of progression to AD (Age: p = .367; Education:
p = .770; Sex: p = .886; NART IQ: p = .970).
Acquisition and delayed recall on RBANS
At baseline, MCI participants showed significant deficits
in acquisition of new material F(1, 32) = 29.509, MSE =
392.32, p < .0001, and delayed recall, F(1,32) = 44.474,
MSE = 307.06, p < .0001), on the RBANS story task
compared with controls (Table 1). MCI participants
scored on average 6.8 points lower than controls for
immediate recall [95% C.I. = 4.25, 9.36] and 6.7 points
lower for delayed recall [95% C.I. = 4.18, 7.86].
AM a n n - W h i t n e yU test revealed a significant differ-
ence between the MCI subgroups for delayed recall on
the RBANS story task, U = 10.5, p = .036. MCIc partici-
pants recalled on average 3.5 details less on their base-
line RBANS assessment in comparison to MCIs
participants [95% C.I. = .4, 6.2] (see Figure 1).
Acquisition of face-name pairs
Mann-Whitney U tests revealed significant deficits in
the MCI group across all face-name learning trials (p <
.0001). Wilcoxon Signed Ranks tests revealed a signifi-
cant difference between Trials 1 and 3 (p = .006) in the
MCI group, with recall of face-name pairs peaking in
Trial 3. In the control group, significant differences fol-
lowing Bonferroni corrections (corrected alpha = .0125)
were found between Trials 1 and 3 (p = .001), Trials 1
and 4 (p = .004), Trials 2 and 3 (p = .004) and Trials 2
and 4 (p = .002). This reflected the increase in learning
across trials. Not surprisingly, controls scored almost at
ceiling on the fourth learning trial of the Face-Name
pairs task with 50% of the sample scoring the maximum
6 points (Mean score: 5.1, SD = 1.2). Of interest here,
however, was the performance of controls versus
patients on the delayed recall subscale of this task (see
below).
A significant difference between the MCI subgroups
was found on Trial 2 of the Face-Name pairs task, U =
7.0, p = .015, with MCIs participants recalling on aver-
age 2.2 face-name pairs in comparison with 0.8 pairs
recalled by the MCIc group (Mean Difference = 1.4;
95% C.I. = .4, 2.8).
Delayed recall of associative items versus associative
pairings
Mann-Whitney U tests showed that controls scored sig-
nificantly higher than the MCI group for delayed pair-
ings (U =4 6 . 5 ,p < .001; Mean Difference = 2.5; 95% C.
I. = 1.2, 3.8) and delayed recall of test names (U =3 1 . 0 ,
Table 1 Baseline performance across episodic memory
subdomains (mean ± SD) for control and Mild Cognitive
Impairment participants.
Assessment Controls
(n = 18)
MCI
(n = 16)
Group
Effect
Acquisition and RBANS immediate
recall
20.6 (2.7) 13.7 (4.5) ***
Delayed Recall RBANS delayed recall 9.8 (2.0) 3.8 (3.2) ***
Associative
Memory
Face Name Trials 1-4 4.2 (1.1) 1.8 (0.5) ***
Face Name delayed 4.3 (1.7) 1.7 (1.9) ***
Face Name free
recall
5.6 (0.7) 2.8 (1.9) ***
Spatial Memory Landmark
Recognition
4.8 (0.9) 3.7 (2.1) n/s
Landmark Location 5.0 (1.5) 4.4 (1.5) n/s
Pointing task errors° 114.6
(62.5)
150.2
(53.1)
n/s
Route Description 13.3 (2.1) 10.5 (3.5) **
HR Recall 8.4 (3.2) 5.5 (3.0) *
HR Recognition 7.7 (1.3) 6.9 (1.5) n/s
HR Temporal Order 16.4 (9.4) 25.0 (6.5) **
Everyday
Memory
MMQ “Yesterday” 23.8 (0.4) 21.0 (2.9) ***
MMQ “1 week ago” 19.4 (5.7) 12.1 (6.7) **
EMQ total score 23.6
(14.0)
62.7
(32.2)
***
* p < .05;* *p < .01; *** p < .001; n/s, non-significant, MCI = Mild Cognitive
Impairment, HR = Hospital Route task, MMQ = Mundane Memory
Questionnaire, EMQ = Everyday Memory Questionnaire
Figure 1 Baseline RBANS story performance for controls, stable
MCI and converted MCI subgroups (Bars represent 95% C.I.)
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Figure 2). Importantly, controls did not show evidence
of a ceiling effect on the delayed recall subscale with
only 6 out of 18 controls (33.3%) scoring the maximum
6 points. No significant diff e r e n c eb e t w e e nt h eM C I s
and MCIc subgroups was present for delayed recall of
face-name pairs (p = .089), however the MCIc subgroup
performed significantly worse than the MCIs subgroup
on delayed associative item memory (U =8 . 0 ,p = .017;
Mean Difference = 1.5; 95% C.I. = -.3, 3.3).
Wilcoxon Signed-Rank tests revealed a significant dif-
ference between Face-Name pairs test subscales for con-
trols with higher delayed recall of names (Mean score:
5.6) in comparison with face-name pairings (Mean dif-
ference = 1.3; Z = -2.725, p = .003; 95% C.I. for differ-
ence = .5, 2.0). This effect was also evident in the MCIs
group, (Names: 3.9, Face-Name Pairs: 2.4; Z = -2.401, p
= .008; 95% C.I. for mean difference = .4, 2.2). However,
for MCIc participants, this effect was attenuated, Z =
-1.732, p = .042, with less pronounced differences
between the average number of names recalled (1.3) ver-
sus the average number of correctly identified face-name
pairs (0.8) [95% C.I. for difference = -.1, 1.3].
Spatial memory performance
A MANOVA revealed a marginally significant difference
between MCI and control participants for Landmark
Recognition, F(1, 32) = 4.102, MSE =1 0 . 0 7 ,p = .051. No
significant group differences were evident on the Land-
mark Location task, F(1,32) = 1.436, MSE =3 . 3 1 ,p =
.240. No significant group effects were observed on the
Pointing Task F(1,32) = 3.778, MSE = 24.87, p = .061. In
contrast, the Route Description task dissociated between
participant groups F(1, 32) = 8.434, MSE = 68.00, p =
.007, with controls scoring on average 2.8 points higher
than MCI participants [95% C.I. = .85, 4.82]. Controls
scored significantly higher than MCI participants for
immediate recall on the Hospital Route task, F(1, 32) =
7.152, MSE = 70.69, p = .012 (Mean Difference = 2.9;
95% C.I. = .69, 5.09). No significant differences between
the participant groups were present for Hospital Route
Recognition F(1, 32) = 3.071, MSE =6 . 0 8 ,p = .089. The
MCI group exhibited significantly poorer accuracy in
reconstructing the correct temporal order of photographs
from the Hospital Route F(1, 32) = 9.365, MSE =6 2 8 . 1 0 ,
p = .004, (Mean Difference = 8.6; 95% C.I. = 2.88, 14.34).
Mann-Whitney U tests did not reveal any significant dif-
ferences between the MCIs and MCIc subgroups for any
of the spatial tasks (all p > .3).
Everyday memory recall
Controls scored significantly higher than the MCI group
for the recall of events that occurred “Yesterday”, U =
55.5, p < .001 (Mean Difference = 3.0; 95% C.I. = 1.6,
4.5), and “Yesterday 1 week ago”, U =4 6 . 5 ,p <. 0 0 1
(Mean Difference = 7.8; 95% C.I. = 3.4, 12.3) on the
MMQ. No significant differences were found between
MCIs and MCIc subgroups for MMQ recall for “Yester-
day” (U = 22.0, p = .350) and “Yesterday 1 week ago” (U
= 25.0, p = .500). Wilcoxon Signed-Rank tests revealed
that controls recalled significantly more detail for “Yes-
terday” compared with “Yesterday 1 week ago”,( Z=
-3.189, p = .001; Mean Difference: 4.4; 95% C.I. = 1.6,
7.2). Similarly, both MCI subgroups recalled more
details for events in closer temporal proximity to the
present day (MCIs: Z = -2.431, p = .015, Mean differ-
e n c e=9 . 5 ;9 5 %C . I .=4 . 2 ,1 4 . 8 ;M C I c :Z = -2.214, p =
.027, Mean difference = 8.6; 95% C.I. = 5.7, 11.6). On
the Everyday Memory Questionnaire (EMQ), MCI parti-
cipants rated their lapses in memory as significantly
higher than control participants, F(1, 32) = 17.95, p <
.0001, (Mean difference = 3.0; 95% C.I. = 1.6, 4.4), how-
ever, Mann-Whitney U tests failed to reveal any differ-
ences in EMQ ratings between stable and converted
MCI subgroups (U = 22.0, p = .356).
Executive Function
At baseline, a MANOVA revealed that MCI participants
were impaired on the Digit span backwards task (p =
.044, Mean difference = 1.5; 95% C.I. = .1, 3.0), Trails B-
A( p = .005, Mean difference = 45.7; 95% C.I. = 19.9,
71.6), Category fluency (p < .0001, Mean difference =
12.3; 95% C.I. = 6.4, 18.2) and the Stroop task (p = .012,
Mean difference = 20.7; 95% C.I. = 5.2, 36.1) in compar-
ison with controls [28]. Mann-Whitney U tests failed to
reveal any significant differences between MCIs and
MCIc participants on any of the tests of executive func-
tion at baseline (all p > .3).
Exploratory prediction of conversion to AD
The tasks which differentiated between controls and
MCI participants at baseline, and between MCIs and
Figure 2 Delayed associative pairings and item recall on the
Face Name task at baseline for controls, stable MCI and
converted MCI subgroups (FN = Face Name; Bars represent
95% C.I.)
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task and the RBANS story recall task. These tasks were
included as predictor variables in a series of exploratory
independent regression analyses. Figure 3 shows the
individual predictive power of the four test variables of
interest (Face-Name delayed name recall and delayed
face-name pairs recall, and RBANS story immediate
recall and delayed recall), ranked in ascending order
according to the magnitude of their odds ratios. Delayed
recall of names on the Face-Name pairs task emerged as
the best predictor of conversion to AD in this sample
(Associative item memory; p = .008; Odds ratio = 2.8,
95% C.I. = 1.3, 6.0; Nagelkerke R square = .564), with
the regression model correctly classifying 88% of partici-
pants. This was followed by delayed face-name pairings
(Associative pairs memory; p = .030; Odds Ratio = 2.3,
95% C.I. = 1.1, 4.7; Nagelkerke R square = .378), the
RBANS story delayed recall (p = .032; Odds Ratio = 1.9,
95% C.I. = 1.1, 3.5; Nagelkerke R square = .563), and
the RBANS story immediate recall (p = .011; Odds Ratio
= 1.4, 95% C.I. = 1.1, 1.9; Nagelkerke R square = .466).
Figure 4 shows the cumulative survival function across
time for MCI and control participants (bvFTD patient
excluded, n = 33) scoring above and below the Face-
Name associative item memory threshold score of 3.
Visual examination of score distributions on scatterplots
was used to select the threshold score of 3 for the Face-
Name associative item memory subscale. The resulting
regression model revealed that the Face-Name associa-
tive item memory threshold variable was a significant
predictor of conversion to AD in the regression equa-
tion (b = -1.092, p = .012) with an odds ratio of 3.0
[95% C.I. for odds ratio = 1.3, 7.0]. Using this cut-off
score of below 3 on the Face-Name associative item
memory subscale achieved a sensitivity of 1.0 and a spe-
cificity of .86.
Discussion
The objective of this study was to investigate the nature
o ft h ee p i s o d i cm e m o r yi m p a i r m e n ti nM C Iu s i n g
experimental tasks with direct impact on everyday func-
tioning and relevance for patients in their everyday lives
(e.g., story-telling, remembering faces and names, spatial
navigation, and everyday memory). MCI participants
were significantly impaired across all domains of episo-
dic memory assessed, with the greatest baseline deficits
evident on episodic memory tests of acquisition, delayed
recall and associative memory. Longitudinal follow-up
data suggested that delayed associative memory perfor-
mance at baseline may have some predictive utility for
subsequent conversion to probable AD. This intimates
that a simple Face-Name pairs test may have the poten-
tial to be a useful neuropsychological task for identifying
individuals in the prodromal stage of AD.
Exploratory findings: Potential predictive power
of Face-Name pairs task
The most significant finding to emerge from this study
concerns the associative memory deficits evident in the
MCI group, which were detectable at baseline using a
simple Face-Name pairs task. Of note for future studies
are our preliminary findings using a cut-off score of 3
names on the delayed associative item subscale of the
Face-Names pairs task at baseline for the prediction of
conversion from MCI to probable AD within two years.
Critically, the percentage of converted MCI participants
in our sample mirrors the conversion rates previously
reported [29] allowing us some confidence in our
results. The predictive efficacy of the Face-Name pairs
task (88%) is encouraging given that multivariate combi-
nations of episodic memory tasks with executive func-
tion, recognition memory, visuospatial memory
processing speed and visuospatial episodic memory tests
have demonstrated lower classification accuracy than
our current findings (84% [4]). Our data build on the
current view that associative episodic memory tests
Figure 3 Odds ratios from exploratory individual regression
analyses using Face Name and RBANS story experimental tasks
as predictors for conversion from MCI to AD (FN = Face Name,
Bars represent 95% C.I.)
Figure 4 Exploratory cumulative survival function using Face-
Name task delayed associative item recall to predict
conversion from MCI to AD (Bars represent 95% C.I.)
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suggest here that there is considerable scope to incorpo-
rate episodic memory tasks with real-life relevance for
participants into future larger-scale longitudinal studies,
with the goal of arriving at an optimal diagnostic battery
that can successfully identify those MCI individuals in
the prodrome of clinically probable AD.
While delayed associative item performance was nota-
bly impaired in MCI, significant episodic memory
impairments were also detectable for the acquisition of
face-name pairs across trials and the subsequent reten-
tion of these real-world pairings. This finding is in con-
trast with recognition and forced-choice face-name
associative paradigms which have not revealed differ-
ences between MCI and control participants [11]. The
existence of encoding and retention difficulties in MCI
points towards potential neurodegenerative changes in
the medial temporal lobe regions subserving memory
formation [31], as well as posterior cingulate regions
[32], and possibly more widespread gray matter loss
[33], with medial temporal lobe regions no longer able
to activate during attempted learning [11]. The observa-
tion of higher scores for delayed recall of names (asso-
ciative item) compared with delayed recall of face-name
pairs (associative pairs) pointed towards a differential
profile of associative deficits in controls and MCI parti-
cipants. Controls’ performance supported the Associa-
tive Deficit Hypothesis [34], which specifies that older
adults exhibit a unique deficit for associations over and
above their deficits, if any, in item memory. Importantly,
on the delayed associative subscale, only 6 out of 18
controls (33.3%) correctly remembered all 6 Face-Name
pairs, ruling out the possibility of ceiling effects in this
sample. Interestingly, both MCI subgroups showed a
similar pattern to controls albeit at a lower level, how-
ever the deficit for associations was attenuated in the
converted MCI subgroup and may reflect a floor effect.
We suggest the converted MCI subgroup’s impairments
are an artefact of associative encoding difficulties, pre-
cluding the formation of an association between face
and name, and retention deficits which were evident at
delayed recall. This dovetails nicely with reports that
MCI individuals with learning and retention deficits at
baseline show a significantly higher likelihood of devel-
oping AD over two years [33].
Acquisition of material in MCI
Further deficits in the encoding and retention of new
material were evident on the RBANS story task, with
MCI participants displaying significant impairments in
immediate and delayed story recall. This mirrors the
common complaint of MCI individuals not remember-
ing stories that are recently relayed and suggests
impaired executive functioning [35]. Indeed,
performance on the Trail Making Test was inversely
correlated with RBANS delayed recall (p < .0001). Using
percentage retention scores [36], the aggregated MCI
sample at baseline obtained a retention percentage of
55% in comparison with 96% for controls. Interestingly,
the stable MCI subgroup retained 72% of the story in
comparison with 28% for the converted MCI subgroup,
corroborating optimal diagnostic accuracy indices of
scores < 50% retention to distinguish AD from MCI
[36].
Impaired spatial memory in MCI
This study builds on previous findings of disrupted spa-
tial memory in MCI during route encoding [25], on an
analogue of the Water maze task [24], and a comparison
of real-world versus virtual-reality spatial navigation
[23]. Consistent with previous studies using similar
methods [25], we have confirmed that spatial memory,
across a number of domains, is disrupted in MCI. Criti-
cally using a novel combination of real-world measures
and pencil and paper tasks, we found a dissociation
between those tasks requiring actual navigation, either
mental (Route Description) or physical (Hospital Route
tasks), and those which relied predominantly on recog-
nition processes (Landmark Recognition and Location)
or mental rotation (Landmark Pointing). Importantly, by
including a longitudinal component, we could investi-
gate the possible predictive efficacy of spatial memory
tasks for conversion to AD. The only tasks that disso-
ciated between MCI and control participants at baseline
were those which required engaging in navigation. This
finding is consistent with previous reports which suggest
that actual navigation recruits different neural regions
than table-top arrays or pencil and paper tasks [37]. The
geographical disorientation found on the Route Descrip-
tion task in the MCI group occurred despite the provi-
sion of cardinal directions and a clear map of the
imaginary city. This finding is important, as similar
decrements in route description have been observed in
the mild stages of AD and these deficits are attributed
to allocentric disorientation [38].
For real-world navigation on the Hospital Route task,
MCI individuals showed significant impairments for
immediate recall and temporal ordering, the latter of
which likely relies on the integrity of the frontal lobes
[39] and may reflect frontal lobe dysfunction in MCI of
a greater magnitude than in non-pathological ageing.
Although recognition of stimuli encountered on the
Hospital Route task was intact in MCI, it has been
noted [25], that landmark recognition likely engages
neural regions that are lost in more advanced stages of
AD such as more posterior medial temporo-occipital
regions [40]. The finding of impaired spatial navigation
and spatial memory in MCI is worthy of further
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possible that the poor predictive power of spatial tasks
is due to the relatively small numbers in the present
study. Importantly, whilst sex was not evenly distributed
between the participant groups, the over-representation
of males in the MCI group did not mask the significant
spatial memory deficits found in this cohort compared
with controls. The relative sparing of spatial recognition
memory in MCI warrants further attention, particularly
where the functional capacity of the individual is con-
cerned, given that topographical disorientation is often
one of the initial manifestations of AD [38,41] and likely
contributes to the compromised capacity to carry out
such activities of daily living as shopping and travelling
unaccompanied.
Everyday mundane memory and insight in MCI
In keeping with studies documenting compromised
retrieval of past events in MCI [13,28], everyday mem-
ory for the previous day and week was impaired in our
MCI cohort. At baseline, MCI participants exhibited sig-
nificant deficits in retrieving contextual details for the
“mundane” events of the previous day and one week
prior, such as failing to remember the clothes they
wore, where they had been, and who they had met. In a
previous study [28], recall of contextual details from
autobiographical memories (ABMs) across the lifespan,
including an experimentally-verified event that occurred
one week previously, was found to be compromised in
this MCI cohort. Successful recall of the minutiae of the
previous day and week may rely more on overgeneral or
semanticised schemas that are relatively preserved in
contrast with contextually rich episodic ABMs mediated
by medial temporal lobe structures known to be affected
in MCI [13]. Of interest is the finding of significantly
higher subjective ratings of everyday memory lapses in
the MCI group compared with controls, indicating a
degree of insight into their deficits. The level of aware-
ness for memory functioning has been shown to vary in
MCI [42], whereas lack of insight into deficits is consis-
tent with the typical presentation of patients with AD
[43]. Further investigation of these differences in self-
awareness is therefore warranted, as this may represent
an important distinction between MCI and AD patient
groups, as impaired awareness of one’s deficits makes an
important contribution to functional decline [44,45].
Additionally, how the everyday episodic memory deficits
demonstrated here impact on the daily activities of the
MCI patient is an interesting, but unresolved, question
worthy of further investigation. It is likely that the
impairments across the domains of encoding, associa-
tive, spatial and mundane memory impact on the every-
day activities of the MCI individual. This represents an
important area for future research, particularly in terms
of elucidating how such episodic memory deficits relate
to behavioural changes reported by the patient and/or
their informant, or whether these changes relate to carer
stress. Whether such deficits are amenable to cognitive
retraining is a further issue of critical importance.
Executive function in MCI
Despite the apparent preservation of insight into their
deficits, the MCI group showed significant impairments
on tests of executive function at baseline (Category Flu-
ency, Trails B-A, and Stroop, see [28], suggesting diffi-
culties with set-switching and response inhibition. Given
the importance of the frontal lobes in spatial and non-
spatial episodic memory [46,47] it is not surprising that
the MCI group exhibited significant decrements on
many of the memory tasks used in this study. However,
no significant differences were present between the
MCIs and MCIc subgroups for baseline performance on
the executive tasks. In addition, these tasks did not pre-
dict conversion to AD. This finding may reflect the pur-
posive selection of multi-domain MCI participants,
which may truncate the MCI sample by excluding indi-
viduals with mild executive deficits, such that any poten-
tial relationships between the test variables are obscured
[48]. It would therefore be worthwhile to investigate the
combined predictive power of associative episodic mem-
ory tasks and measures of executive function in this
respect.
A number of limitations should be considered in light
of the current findings, primarily the small sample from
which we base our conclusions. While the emergence of
significant findings in a sample this small provides
encouraging preliminary findings, it is possible that our
results are specific to the present sample and may not
generalise to all cases with MCI. Future studies are
clearly warranted to investigate these effects in a larger
sample of both single-domain and multi-domain amnes-
t i cM C Ic a s e s ,a l l o w i n gu sm o r ec o n f i d e n c ei nt h eg e n -
eralisablity of the current findings. The interval between
baseline and follow-up varied across participants,
although a regression analysis showed that time elapsed
between baseline and follow-up testing did not predict
conversion to AD. Control participants were not fol-
l o w e du pl o n g i t u d i n a l l ya sp a r to ft h i ss t u d ya st h e
emphasis was on identifying important prodromal mar-
kers of AD in MCI. It will be important for future stu-
dies to follow controls longitudinally to garner further
data regarding age-related changes in healthy indivi-
duals. While it is unlikely that any of the controls in the
present sample were in the early stages of a dementing
process, given that changes in cognition are typically
detectable from 5 to 6 years prior to diagnosis of AD
[49], longitudinal follow-up data for controls would
allow us greater confidence in the regression
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and high-functioning individuals. Finally, structural neu-
roimaging data should be incorporated into future longi-
tudinal studies of everyday episodic memory to
investigate the degree of hippocampal atrophy in the
MCI participants as an index of disease trajectory,
which is in itself predictive of rapid conversion to AD
[50].
Conclusions
In summary, this study has explored the decline of epi-
sodic memory in amnestic MCI across the real-world
domains of story acquisition and recall, face-name pairs
association, spatial memory and navigation, and mun-
dane everyday memory. The MCI patients who subse-
quently converted to AD exhibited a specific profile of
episodic memory deficits that was detectable at the
baseline visit, notably on tests of delayed associative
recall. Using longitudinal data, we found that the
delayed associative item subscale of the Face-Name
pairs task may hold some predictive utility as a diagnos-
tic aid within the clinical setting. While these results
need to be replicated in longitudinal studies with larger
samples and follow-up data for controls, our current
results support the view that episodic memory tasks
with real-world relevance are important to assist in the
identification of MCI individuals who may convert to
AD within a relatively short period of time. It is crucial
to identify MCI individuals who are likely to convert to
AD in the very early stages, facilitating swift intervention
with anticholinergic drugs, for which the earlier the
treatment the better the long-term outlook [51]. The
creation of a neuropsychological test that can reliably
predict those MCI cases that will progress to AD
remains the “holy grail of neuropsychology” [52].
Furthermore, the implementation of neuropsychological
assessments that can be understood by the patient as
having relevance to their everyday life is imperative.
Based on this preliminary study, a simple associative
memory task such as the encoding and retention of
face-name pairs represents a promising line of enquiry
for future investigations.
Methods
Participants
MCI Recruitment
A sample of 16 unmedicated individuals with a diagno-
sis of amnestic MCI were recruited through the Mer-
cer’s Institute for Research on Aging (MIRA) memory
clinic and diagnosed by a consultant-led multi-disciplin-
ary team using the consensus criteria from the Interna-
tional Working Group on Mild Cognitive Impairment
[1] and the MCI Working Group of the European Con-
sortium on Alzheimer’s disease criteria [53]. The
diagnostic work-up included an interview with the indi-
vidual and a reliable informant covering current and
past personal and medical history, current health and
mental status, physical and neurological exam, routine
laboratory screen, ratings of functional status and beha-
viour, and neuropsychological testing. MRI or CT brain
scan was done as a routine part of the work-up. The
consensus-based multi-disciplinary team diagnosis of
amnestic MCI was conferred if the individual’sm e m o r y
deficits fell at least 1.5 standard deviations below age-
adjusted normative scores on at least one standardised
test of memory including the Cambridge Cognitive
Examination CAMCOG [54] and the Delayed Word
Recall (DWR) test [55,56] in the context of preserved
functional capacity. In the case of MCI individuals with
high pre-morbid ability who did not score at least 1.5 S.
D. below age-adjusted norms on these tests, the Wechs-
ler Memory Scale Immediate and Delayed Logical Mem-
ory sub-tests (WMS-III; [57]) and the Rey Osterrieth
Complex Figure test (Copy and recall; [58]) were also
included to ensure that memory deficits were present.
Further neuropsychological tests for all MCI patients
included verbal fluency (FAS test) and semantic category
fluency [59], and the Boston Naming Test - 30 item
[60].
The memory deficits exhibited by the MCI partici-
pants were subjectively reported by the MCI individual
and corroborated by an informant. Emphasis was placed
on the preserved functional capacity of the individual,
which was determined based on informant report using
the Instrumental Activities of Daily Living scale (IADL)
and the Personal Self Maintenance Scale (PSMS) [61].
Where basic activities of daily living were preserved and
complex instrumental functions were either intact or
minimally impaired, the patient was deemed to be func-
tionally capable. Specifically, they did not fulfil criteria
for dementia. The majority of MCI participants in this
sample were diagnosed with multi-domain MCI (n =
13), exhibiting deficits in memory and executive func-
tioning, whilst the remaining 3 participants received a
diagnosis of single-domain MCI, with deficits residing
exclusively within the domain of memory [62]. MCI
cases were recruited for this study within 6 months of
their diagnosis to ensure that the data collected were
representative of patients’ current disease state.
Control Recruitment
Eighteen controls were sourced from a local Active
Retirement Association, and were screened prior to tak-
ing part to exclude for any neurological complaints, a
prior serious head injury, history of psychiatric illness or
alcohol abuse.
General Cognitive Screening
Prior to administration of the experimental tasks, gen-
eral cognitive screening for all participants (MCI and
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(MMSE, [63]), the Clock Drawing Test (10 point scoring
system, [64]), the National Adult Reading Test (NART,
[65]), the Geriatric Depression Scale - 15 item version
(GDS-15, [66]) and the Instrumental Activities of Daily
Living scale (IADL, [61]). Controls scoring < 27 on the
M M S Eo r<8o nt h eC l o c kD r a w i n gT e s tw e r e
excluded, as were any participants scoring > 7 on the
GDS-15, which was taken as indicative of pervasive
depression (see [67]). Furthermore, all controls scored
within normal limits on the Word List Memory subtest
from the Consortium to Establish a Registry for Alzhei-
mer’sd i s e a s e( C E R A D-W o r dL i s t ;[ 6 8 ] ) .E t h i c a l
approval was obtained from the St. James’s Hospital and
Adelaide and Meath Research Ethics Committee and all
participants gave informed consent prior to testing in
accordance with the Declaration of Helsinki (1991).
Assessment of episodic memory
Episodic acquisition
The “Story memory” component from the immediate
memory index of the Repeatable Battery for the Assess-
ment of Neuropsychological Status (RBANS) [69] was
used to assess acquisition and learning. A short story
describing a house fire, containing 12 key details, was
read aloud to participants over two trials, and partici-
pants were asked to recall the story in as much detail as
possible immediately following each encoding trial. This
led to a total maximum score of 24 for Immediate
Recall (2 × 12). Delayed recall of the story was assessed
15 minutes following encoding (maximum score of 12).
Scoring was based upon verbatim recall with one point
awarded for each detail correctly retrieved.
Associative memory
A modified Face-Name pairs task [70] was used com-
prising 6 black and white face stimuli (hair included)
and 6 accompanying first names presented across four
encoding blocks. Participants were shown each face sti-
mulus on an A4 page with its corresponding first name
adjacent to the picture, one at a time, at a rate of one
every 2 seconds and were asked to commit the names
to memory under intentional learning conditions [34].
At recall, participants were shown the face stimuli in a
new randomised order and asked if they could remem-
ber the corresponding name for each face. This encod-
ing and immediate recall procedure continued across 4
trials. One point was awarded for each correctly named
face, with a maximum score of 6 points per trial. A con-
structional praxis distraction task was completed to pre-
vent rote rehearsal between encoding and recall blocks.
All stimuli were randomised to prevent order effects
and to ensure the association between the face and
name was being recalled. Delayed recall was assessed 30
minutes following encoding using the face stimuli as
cues in a newly randomised order (Maximum Score =
6). Participants were told they would see the facial sti-
muli again and were asked to remember the correct
name for each face. Free recall was assessed at the end
of the Face-Name test session by asking participants to
recall as many names as they could without being able
to see the facial stimuli. This provided information
regarding the associative encoding of the name stimuli
versus the associative binding of faces-name pairs.
Landmark recognition and location
To gauge participants’ familiarity with Dublin city, prior
to the administration of the Landmark Pointing test (see
below), participants were required to identify six well-
known landmarks from Dublin city, from colour photo-
graphs of the canonical view of each landmark [71]. Par-
ticipants were shown each photograph one at a time and
asked which well-known Dublin landmark was depicted.
One point was awarded for each correct answer (Recog-
nition Max score = 6). An additional point was awarded
if participants could accurately locate each landmark on
a blank map of Dublin City Centre with all spatial infor-
mation omitted. Participants were shown the 6 colour
photographs one at a time and asked to point to the
corresponding letter on the map denoting the correct
location for the landmark. The only defining features on
the map included the River Liffey dividing the city into
North and South and the letters A-F, which represented
the location of the six different landmarks (Location
Max score = 6).
Landmark pointing task
Participants stood on a large laminated compass affixed
to the floor, facing 0 and pointed to the six landmarks
from the Landmark Recognition task. They were
instructed to imagine themselves standing in front of
one of the six landmarks and to point in the direction
of each of the remaining five landmarks in turn, as
though giving directions to somebody unfamiliar with
the city [72]. This was repeated across three trials origi-
nating from three different starting locations in the city
centre. The accuracy of pointing was established by
dropping a plumbline from the participant’sf i n g e rt o
the compass on the floor and the experimenter read off
the corresponding angle from the compass. The degree
of error was calculated by subtracting participants’ mea-
surements from the correct set of angles taken by the
experimenter using Google Earth, with an average error
score calculated across the three starting points for each
participant.
Route description task
A black and white map of a virtual city was presented,
and participants were instructed to give directions to
someone going from point × to point Y describing the
best possible route [71]. The map contained a series of
s t r e e t sa n db u i l d i n g sw i t hn o defining features. Four
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marks (A, B, C, D), and the compass points of North,
South, East, West were included as a reference. Partici-
pants were asked to narrate their chosen route aloud
and could trace the route with a pencil or finger to
show the experimenter their trajectory. The experimen-
ter documented each response verbatim. Each route was
broken down into a number of requisite steps, generat-
ing maximum points of 9, 5, and 6 points for routes A
to B, B to C, and C to D, respectively (Maximum score
= 20). Where a participant deviated from the correct
route, or provided ambiguous directions, no points were
awarded for those directions. One mark was awarded
for each correct step, irrespective of whether an incor-
rect step occurred at any point in the sequence.
Hospital route navigation task
A real-life analogue of topographical memory was
designed to test participants’ free recall of a route they
physically traversed within the hospital grounds, with
one change of floor and one change of building. The
experimenter accompanied participants on the route
and narrated the course of the journey, pointing towards
specific proximal landmarks, and highlighting changes of
direction, turns, and floor changes. Immediate free recall
of the route was tested without any prompts (Route
Acquisition) and scored according to 15 steps including
direction, building and floor changes, and salient land-
marks (Max score = 15). For Route Recognition, partici-
pants were shown 10 colour photographs comprising 5
“correct” and 5 “lure” stimuli and were awarded 1 point
for each correct answer, i.e. correctly identifying a target
stimulus and correctly rejecting a lure stimulus (Max
score = 10). Route Temporal Order was assessed by ask-
ing participants to organise 10 photographs from the
traversed route, according to the order in which they
were encountered. The absolute difference between the
participants’ order and the correct temporal order was
calculated, with higher scores reflecting poorer perfor-
mance on the task.
Everyday memory
The Mundane Memory Questionnaire (MMQ) [71] is a
twelve-item questionnaire which probes the recall of a
“typical” day, covering two time periods, “Yesterday” and
“Yesterday One Week ago”. Participants are asked a ser-
ies of questions in a structured format, which follows
the temporal order of a “typical” daily routine from
morning to evening (e.g. getting dressed, travelling to
work, the weather that day, receiving letters, meeting
friends, eating lunch, shopping, reading, work around
the house, watching television, making phone calls that
evening). In this study, the MMQ was modified by
changing work-related questions to reflect everyday
i t e m ss u c ha sl e a v i n go n e ’s house and means of trans-
port that day. The questions proceeded as follows, “Do
you recall getting dressed on this day? If so, what did
you wear?” One point was awarded for a “Yes” response
for each question with an additional point awarded for
provision of details specific to that question (Max score
per time period = 12 × 2 = 24). No points were awarded
for a “No response” indicating failure to recall, or the
failure to provide specific details. The MMQ was origin-
ally validated in a sample of 422 healthy adult volunteers
and has been shown to demonstrate good overall relia-
bility (Cronbach’s alpha = .85) [71].
T h eE v e r y d a yM e m o r yQ u e s t i o n n a i r e[ 7 3 ]w a sa l s o
administered to participants as an index of subjective
awareness of memory lapses that have occurred over the
preceding 3 months. Participants were asked to read 28
statements pertaining to various memory problems, and
indicate the frequency with which they had noticed that
particular memory lapse, ranging from “Not at all in the
last 3 months” (0 points) to “More than once a day” (9
points). Higher scores were indicative of greater memory
problems with possible scores ranging from 0 to a maxi-
mum score of 252 (= 28 × 9).
Executive Function
To fully understand the extent of executive dysfunction
in the MCI group, all participants completed the follow-
ing tests; (1) Digit Span and Spatial Span subtests of the
Wechsler Memory Scale III [57]; (2) Controlled Oral
Word Association Test (COWAT; CFL [74]); (3) Cate-
gory Fluency (fruit, vegetables, animals); (4) Trail Mak-
ing Test Parts A and B [75]; (6) Stroop Test (pencil and
paper version) [76]. These data have been reported pre-
viously [28].
Follow-up of MCI participants
As part of their ongoing clinical care, all MCI partici-
pants re-attended the MIRA memory clinic, approxi-
mately within two years of the baseline visit (Mean time
elapsed 22.4 months ± 9.5). This resulted in an attrition
rate of 0 for follow-up data. In keeping with the diag-
nostic procedure described above, all MCI participants
were re-tested using the same neuropsychological test
b a t t e r ya n dt h es a m ed i a g n o s t i cw o r k - u pw a su n d e r t a -
ken, but MRI/CT were not routinely repeated. The
experimental everyday memory tasks were not re-admi-
nistered at follow-up. Informants were interviewed to
obtain a history of decline and loss of function (if any)
for the patient over the intervening time period. The
multi-disciplinary team reviewed each case and decided
whether the patients represented (a) progression to
dementia (APA 1994), which depended particularly on
whether or not there was evidence of functional decline
on standardised ratings of functional status; (b) if pro-
gressed to dementia, was it clinically probable AD based
on NINCDS-ADRDA criteria (i.e. scores on neuropsy-
chological tests falling below 2 SD compared to age-
adjusted norms) [77]; (c) stable MCI based on the
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Page 10 of 13Winblad et al. [1] and Portet et al. [53] criteria for MCI;
or (d) an improvement from baseline.
Statistical Analyses
Multivariate analyses of variance (MANOVA) were used
to investigate group differences at baseline (Control,
MCI) across demographic and screening variables, with
nonparametric tests used for non-normally distributed
variables. Ninety-five % confidence intervals (CI) were
calculated and Bonferroni corrections were used for
multiple comparisons. Backwards multiple regression
models were run to investigate the predictive effect of
demographic and screening variables for conversion to
AD. Converted MCI (MCIc) were compared to stable
MCI (MCIs) cases using nonparametric Mann-Whitney
U tests. Sex was included as a covariate in all between-
group analyses. A series of binary logistic regression
analyses for all participants combined were run for each
variable of interest to determine odds ratios and 95% C.
I.s for potential predictors of conversion to AD. Nagelk-
erke R-square values were calculated for each of the
regression analyses, as an additional confirmatory esti-
mate of the relative importance of the memory mea-
sures as potential predictors of conversion to AD. A
Cox-Exploratory regression survival analysis was also
run for all MCI and control participants combined
(bvFTD patient excluded, n = 33) as an exploratory step
to investigate potential predictors of conversion to AD
at follow-up.
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